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Summary
BACKGROUND: The European Consensus Statement of
Neonatal Hearing recommended universal newborn hear-
ing screening (UNHS) in 1998. UNHS was introduced in
Switzerland in 1999 under the auspices of a “Swiss Work-
ing Group Hearing Screening in Newborns”.
The aim of this study was to evaluate the number of new-
borns being screened and consequently followed-up in
Switzerland for the year 2012.
METHODS: Postal questionnaires were sent to all re-
gistered maternity clinics and birth-centres in Switzerland.
To evaluate follow-up of newborns failing the screening
process, a retrospective consecutive cohort analysis of
newborns failing screening at the University Hospital
Zurich between 2005 and 2010 was performed.
RESULTS: A total of 102/110 (92.7%) maternity clinics
and 1/14 (7.1%) birth-centres routinely performed UNHS.
When weighted according to the number of births in the
varying locations, 97.9% of all newborn received hearing
screening. At the University Hospital of Zurich, 253/
12,080 (2.1%) newborns failed the screening test and in
15/253 (6%) a relevant bilateral hearing impairment was
found. This makes an overall incidence of congenitally rel-
evant hearing loss of 0.12%. Unfortunately, 33/253 (13%)
of newborns with failed screening were lost to follow-up.
CONCLUSION: UNHS is well-established in Switzerland
and the vast majority of newborns are screened. However,
follow-up of failed screens is disappointing. Further meas-
ures need to be taken to improve follow up.
Key words: universal newborn hearing screening; hearing
loss; early intervention; congenital hearing loss
Introduction
Universal newborn hearing screening (UNHS) was recom-
mended in 1998 in the European Consensus Statement on
Neonatal Hearing Screening in Newborns [1]. In Switzer-
land, UNHS was introduced in 1999 under the auspices
of the “Swiss Working Group: Hearing Screening in New-
borns”. This working group included representatives of the
Swiss societies for otorhinolaryngology (ENT), paediat-
rics and neonatology, and developed the necessary founda-
tions for UNHS in Switzerland. The working group recom-
mends that screening should be performed by estimating
otoacoustic emissions (OAEs) during hospitalisation on the
maternity ward. (Women in Switzerland typically spend
several days on the maternity ward even after an uncom-
plicated birth.)
OAEs are completely safe for the baby and screening is
generally performed between the 2nd and 4th day after
birth [2]. The test takes a few minutes and is able to assess
the cochlear function of a newborn. OAEs utilise the nat-
ural phenomenon of sound echoes from the outer hair cells
of the cochlea following a sound stimulus, and can be re-
corded in 99% of normally hearing ears. The response can
be absent for technical reasons (e.g. poorly fitting probe,
excessive background noise, ear wax, middle-ear effusion)
and is generally absent in ears with a hearing loss of 30 dB
or greater [3]. The test may be performed by a semiskilled
person without specialist knowledge, (e.g. a nurse or mid-
wife after instruction; fig. 1).
The Swiss Working Group has decided that screening is
passed if the OAEs are detectable in at least one ear. If
both ears fail, further investigation, usually with a second
OAE measurement on the same or next day, is recommen-
ded. If during maternal admission no OAEs are detectable
on either side, the child is referred for further investigation
within the first few months of life.
Figure 1
Newborn hearing screening with measurement of automated OAE.
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The first aim of our present study was to evaluate how
widespread UNHS was in Switzerland in 2012. We also
wanted to investigate the implications of a failed screen by
retrospectively evaluating records of the University Hospit-
al Zurich in order to determine how many newborns were




All birth clinics officially registered in Switzerland were
contacted in February 2012 by postal questionnaire (table
1). These clinics were of two types: firstly, hospital mater-
nity wards, which are generally midwife-run and doctor-
supervised; secondly, purely midwife-run “birth-centres”
(“Geburtshaus” in Swiss German; “maison de naissance”
in French). It should, of course, also be said that some wo-
men in Switzerland give birth at home, with or without
medical supervision. These births could not be included in
our analysis.
Institutions that did not respond within 6 weeks were con-
tacted by telephone. The number of births at each institu-
tion was recorded from the birth register.
If an institution replied that it did routinely perform hearing
screening, it was assumed at 100% of children born in this
institution had screening. This is clearly a substantial as-
sumption, but we did not have direct access to patient re-
cords. We then correlated the number of births in each
institution with whether or not they routinely performed
screening to give as an overall estimate of how many new-
borns in Switzerland undergo screening.
Follow-up estimation
To investigate the follow-up of newborns failing the
screening process, a retrospective consecutive cohort ana-
lysis of all neonates born in the years 2005‒2010 at the
University Hospital of Zurich was carried out. Data were
extracted from the electronic hospital database. Preterm ba-
bies of less than 34 weeks gestation were excluded as all
premature infants receive thorough follow-up separately
from the screening programme because of the increased
risk of hearing impairment.
Data analysed included timing and type of follow-up test-
ing (e.g. OAEs, brainstem audiometry, free field play audi-
ometry, side specific audiometry etc.), as well as the ulti-
mate diagnosis and treatment.
Results
A total of 110 maternity wards and 14 birth-centres are
officially registered in Switzerland. All were successfully
contacted and returned the questionnaire. A total of 102/
110 (92.7%) maternity clinics and 1/14 (7%) birth-centres
routinely perform UNHS. When the data are appropriately
weighted according to the number of births, 97.9% of all
newborns are screened (table 2). Of note, all institutions
with >160 births per year performed screening.
Screening
All institutions performed UNHS by measuring otoacoustic
emissions (OAEs). Fifty percent of institutions only test
one ear if this passes the screening; the remaining institu-
tions routinely test both ears.
In 88% of the institutions the test is made by nurses/mid-
wifes and in the remainder by doctors or audiometrists.
Costs in 81.6% of institutions are covered by the institu-
tions themselves, in the others the parents must pay. (We
did not collect data on how much.)
A striking result was that only one of the 14 midwife
led birth-centres performed routine hearing screening, al-
Figure 2
Follow-up of the cohort born in University Hospital Zurich
2005‒2010.
OAE = otoacoustic emission
Table 1: Questionnaire (translated into English from the original German, French or Italian).
Do you perform the newborn hearing screening?
Yes, all No, only when risks No
How do you perform the measurement?
One ear, if this passes the screening Both ears
OAE Other methods (BERA, ALGO)




Do the parents have to pay for the test?
Yes No
Who performs the follow-up of newborns with failed hearing screening?
Again in the maternity clinic / birth-centre
Paediatrician
ENT
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though so few births happen in these institutions that the
impact overall is fairly negligible. All birth-centres that did
not themselves offer routine screening recommended it to
the parents.
Follow-up
The postal questionnaire showed that follow-up of new-
borns who failed UNHS is performed by ENT doctors
(54.4%), paediatricians (29.1%) or again in the birth clinic
(13.6%).
In the retrospective cohort study, 12,080 newborns born
in the years 2005–2010 at the University Hospital Zurich
were analysed. To our best knowledge, 100% of these cases
had screening. A total of 253/12,080 (2.1%) failed the
UNHS and were followed up in our paediatric audiology
unit. The mean age at follow-up was 2.4 months (range
0.2–6.2 months). Of note, the same audiologists perform
the hearing screening and the follow-up in our hospital.
All infants underwent repeat OAEs and 10% had further in-
vestigation with brainstem electrical response audiometry
(BERA). A relevant bilateral hearing loss (of 40dB or
more) was found in 15/253 (5.9%). One of those received
a cochlear implant, the others hearing aids. Figure 2 shows
the care pathway together with patient numbers.
In summary, a total of 15/12,080 (0.12%) of patients were
found to have a relevant bilateral hearing loss. Unfortu-
nately, 33/253 (13%) children failing UNHS did attend
their follow-up appointment and were not contactable ow-
ing to out-of-date details. Given the figures outlined above,
we estimate that perhaps two of these children would have
had a relevant hearing loss. Whether or not these children
were followed up at another institution is unclear.
Discussion
The medical evidence supporting the use of otoacoustic
emissions to screen for congenital hearing loss is well es-
tablished. It is worth noting, however, that only small num-
ber of children who fail their initial screen will ultimately
have a relevant bilateral hearing loss. By finding these chil-
dren early, appropriate further investigation and interven-
tion can help to minimise the impact of hearing loss on
speech/language and social development.
Hearing loss is one of the most common congenital disor-
ders, with an estimated incidence of 1–3/1000 live births
[3–6]. Most neonatal hearing loss is sensorineural and a
known genetic cause is found in 50% of children [7]. Of
these children, approximately 70% have nonsyndromic
deafness, most often related to cochlear hair cell dysfunc-
tion because of errors in production of the gap junction pro-
tein connexin 26 [8]. Other causes of neonatal sensorineur-
al hearing loss include congenital infections such as cyto-
megalovirus, hyperbilirubinaemia and ototoxic medica-
tions [3]. Overall, recognised risk factors are present in
only 50% of infants born with hearing loss [3, 6, 9].
Hearing impairments are not easily detectable on clinical
examination and the newborn generally shows no particu-
lar problems. The infants can behave normally, especially
at the beginning. Without appropriate investigations, con-
genital hearing loss is often only first uncovered years later,
as a result of lack of language development [2]. Indeed, the
average age of detection of hearing loss without screening
is 2.5–3 years of age [2]. Furthermore, without early in-
tervention, children with hearing loss demonstrate predict-
able irreversible deficits in communication and psychoso-
cial skills, cognition and literacy [3]. The positive effect
of early intervention and early care with hearing aids com-
pared with a later onset of intervention is proven [10]. Fur-
thermore, screening has been shown to be cost effective,
greatly reducing future treatment and loss of productivity
costs [11, 12].
The characteristics of a good screening programme are de-
scribed elsewhere [13]. Specifically in terms of UNHS,
a German paediatric audiology consensus in 2001 recom-
mended a screening rate of >95%, a screen-fail <4% and
appropriate follow-up of >95%. In addition, the audiolo-
gical diagnosis should be confirmed within an appropriate
time-frame, namely within the first 3 months of life, and
the intervention should begin in the first 6 months of life
[13].
In Switzerland, as in many European countries and the
USA, UNHS is either recommended or already established
and regulated by law [14]. In some countries, however,
despite being recommended, UNHS is not reimbursed by
standard health insurance.
Despite a successful pilot project [2] and the recommend-
ations of various societies, UNHS is not reimbursed by
the standard health insurance in Switzerland. Internally, in
the University Hospital Zurich, we estimate that the actual
cost of performing screening is roughly 25–30 CHF per pa-
tient. This takes into account the set-up costs of the equip-
ment and training, as well as the ongoing costs of main-
tenance and personnel time. The patient’s health insurance,
however, is charged a fixed rate for the birth and stay on
the maternity ward, and there exists no specific possibility
to charge for the screening. Once a screening test has been
failed, however, the patient is then followed up as an outpa-
tient and the hospital can charge the health insurer via the
Tarmed system.
Screening costs are, therefore, generally carried by the hos-
pitals. Despite this financial drawback, a nationwide survey
in 2008 found that more than 80% of newborns received
screening [15] and our current study estimates 97.9% of
newborns are being screened. This compares to published
Table 2: Universal newborn hearing screening (UNHS) in Switzerland 2012.
UNHS No UNHS Number of births
Maternity clinics (n = 119) 102
93.7%
8 80363
Birth-centres (n = 14) 1
7.1%
13 1074
Number of births 79 721 1716 81437
Screening % 97.9% 2.1% 100%
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data from other countries with, for example, the United
Kingdom having a screening rate of 97.4% in 2006 and
99.7% in 2011 [16]. In Italy the rate in 2003 was 29.3% and
in 2006 was 48.4% [17] and in the USA the rate 2010 was
95% [18].
However, measured against the criteria of the German au-
diological consensus, the Swiss UNHS programme can be
considered only a qualified success. Firstly, it must be em-
phasised that our data are extrapolated from “clinic-level”
information and not from individual patient records. If a
clinic said that they routinely performed hearing screening,
we have assumed a 100% screening rate. This is probably
not true, so the actual screening rate probably lies slightly
below the 97.9% we have calculated. This may well mean a
screening rate of <95%. More worryingly, only 87% of pa-
tients present for follow-up evaluation, well below the re-
commended 95%. Though this is an improvement over the
83% previously reported in a Switzerland [15], there is still
considerable room for improvement. Again, this result is
similar to other countries, with Italy reporting a follow-up
rate of 75%, New York state 89% and Korea 80% [19–21].
As a result, many children who should have further evalu-
ation or treatment are not receiving these services.
The reasons for poor follow-up are probably multiple. A
USA study [22] identified four areas in which there were
barriers to follow-up, namely: lack of service-system capa-
city, lack of provider knowledge, challenges to families in
obtaining services and information gaps. They also iden-
tified five key areas for future programme improvements:
improving data systems to support surveillance and follow-
up activities, ensuring that all infants have a medical
“home”, building capacity beyond identified providers, de-
veloping family support services and promoting the im-
portance of early detection.
Better communication between healthcare providers and
patient tracking would clearly help. Some states of Ger-
many run centralised databases so that children who have
not passed or, indeed, have not been screened, can be iden-
tified and followed up [23].
In the University Hospital Zurich, follow-up takes place at
an average age of 2.4 months. The screening fail rate of
2.1%, with an ultimate relevant bilateral hearing impair-
ment in 0.12% is consistent with published results [6].
Each country will have specific barriers to the uptake of
such screening programmes and their appropriate follow-
up. In Switzerland, UNHS is not regulated by law and, des-
pite what would seem to be an excellent screening rate, our
follow-up still falls short of the recommended quality cri-
teria. This is especially frustrating given our fairly static
population and generally easy access to high quality care.
A particularly striking result from our study is that
midwife-run “birth-centres”, despite having knowledge of
hearing screening, do not offer the service. Instead they in-
form the parents of the recommendation and rely on the
parents seeking out a paediatrician/ENT doctor who can
perform the test within a reasonable time-frame.
Whether a centralised tracking system of all newborns
would improve follow-up is debatable and this clearly has
data protection implications. Appropriate dissemination of
information through relevant specialist societies, public
health campaigns and the like may ultimately prove more
efficacious.
Ideally, we would have performed a study looking at the
records of each and every child born in Switzerland, but
this was not feasible. Lack of information on how many
patients were not screened despite being in an institution
which claims to screen, how many children were born at
home without medical supervision and so on are all limita-
tions of our study. It would also be of great interest to un-
derstand better what happened to the children who did not
attend follow-up: were they followed-up in another institu-
tion? Did they have hearing problems?
Another aspect which we have not addressed in this study
is the possibility of passing the hearing screening, but still
having a relevant hearing loss. There is very little literature
as to the likelihood of a false positive OAE, although,
anecdotally, we do occasionally see children who present
as toddlers with relevant hearing loss despite a supposed
normal screening. These children usually present because
of poor language development or behavioural issues. The
reason for this failure of the screening procedure could the-
oretically be a false positive screen, a retrocochlear patho-
logy with intact hair cell function, or a progressive/delayed
hearing loss.
Conclusions
The data presented in this article provide an estimate of
the number of newborns undergoing hearing screening in
Switzerland. The results show an improvement over the 5
years since the latest similar data were published. There
is, however, still room for improvement. Exactly how this
can be achieved is not clear, although it will probably in-
volve close co-operation between parents, midwives, pae-
diatricians, ENT doctors and, ultimately, the cost-carriers,
be they the insurance companies, government or other. We
hope, however, with this study to have raised the general
awareness of UNHS and intend to revisit the topic in due
course.
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Figures (large format)
Figure 1
Newborn hearing screening with measurement of automated OAE.
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Figure 2
Follow-up of the cohort born in University Hospital Zurich 2005‒2010.
OAE = otoacoustic emission
Original article Swiss Med Wkly. 2013;143:w13905
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 7 of 7
